162 related articles for article (PubMed ID: 24324372)
1. The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas.
Liang R; Fan Y; Wang X; Mao Q; Liu Y
ScientificWorldJournal; 2013; 2013():403942. PubMed ID: 24324372
[TBL] [Abstract][Full Text] [Related]
2. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.
Neal A; Kwan P; O'Brien TJ; Buckland ME; Gonzales M; Morokoff A
Epilepsy Behav; 2018 Jan; 78():30-36. PubMed ID: 29172136
[TBL] [Abstract][Full Text] [Related]
3. IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients.
Zhong Z; Wang Z; Wang Y; You G; Jiang T
Epilepsy Res; 2015 Jan; 109():100-5. PubMed ID: 25524848
[TBL] [Abstract][Full Text] [Related]
4. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
[TBL] [Abstract][Full Text] [Related]
5. IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis.
Li Y; Shan X; Wu Z; Wang Y; Ling M; Fan X
Seizure; 2018 Feb; 55():76-82. PubMed ID: 29414139
[TBL] [Abstract][Full Text] [Related]
6. Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.
Phan K; Ng W; Lu VM; McDonald KL; Fairhall J; Reddy R; Wilson P
World Neurosurg; 2018 Mar; 111():e539-e545. PubMed ID: 29288860
[TBL] [Abstract][Full Text] [Related]
7. Relationship between IDH1 mutation and preoperative seizure in low-grade gliomas: A meta-analysis.
Wang ZF; Chen HL
Clin Neurol Neurosurg; 2016 Sep; 148():79-84. PubMed ID: 27428487
[TBL] [Abstract][Full Text] [Related]
8. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
[TBL] [Abstract][Full Text] [Related]
9. IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas.
Duan WC; Wang L; Li K; Wang WW; Zhan YB; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZY
Medicine (Baltimore); 2018 Dec; 97(50):e13675. PubMed ID: 30558073
[TBL] [Abstract][Full Text] [Related]
10. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.
Wang Y; Zhang T; Li S; Fan X; Ma J; Wang L; Jiang T
Eur J Neurol; 2015 Feb; 22(2):348-54. PubMed ID: 25318355
[TBL] [Abstract][Full Text] [Related]
11. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas.
Liubinas SV; D'Abaco GM; Moffat BM; Gonzales M; Feleppa F; Nowell CJ; Gorelik A; Drummond KJ; O'Brien TJ; Kaye AH; Morokoff AP
Epilepsia; 2014 Sep; 55(9):1438-43. PubMed ID: 24903073
[TBL] [Abstract][Full Text] [Related]
12. Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis.
Zhang ZY; Chan AK; Ng HK; Ding XJ; Li YX; Shi ZF; Zhu W; Zhong P; Wang Y; Mao Y; Yao Y; Zhou LF
Int J Clin Exp Pathol; 2014; 7(12):8627-36. PubMed ID: 25674227
[TBL] [Abstract][Full Text] [Related]
13. Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas.
Ohno M; Hayashi Y; Aikawa H; Hayashi M; Miyakita Y; Takahashi M; Matsushita Y; Yoshida A; Satomi K; Ichimura K; Hamada A; Narita Y
Neurology; 2021 Nov; 97(21):e2114-e2123. PubMed ID: 34610989
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features and Prognosis of Indonesian Patients with Gliomas with IDH Mutation: Insights into Its Significance in a Southeast Asian Population.
Malueka RG; Dwianingsih EK; Bayuangga HF; Panggabean AS; Argo IW; Donurizki AD; Shaleh S; Wicaksono AS; Dananjoyo K; Asmedi A; Hartanto RA
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2287-2295. PubMed ID: 32856857
[TBL] [Abstract][Full Text] [Related]
15. The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas.
Wang HY; Tang K; Liang TY; Zhang WZ; Li JY; Wang W; Hu HM; Li MY; Wang HQ; He XZ; Zhu ZY; Liu YW; Zhang SZ
J Exp Clin Cancer Res; 2016 May; 35():86. PubMed ID: 27245697
[TBL] [Abstract][Full Text] [Related]
16. Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.
Mukasa A; Takayanagi S; Saito K; Shibahara J; Tabei Y; Furuya K; Ide T; Narita Y; Nishikawa R; Ueki K; Saito N
Cancer Sci; 2012 Mar; 103(3):587-92. PubMed ID: 22136423
[TBL] [Abstract][Full Text] [Related]
17. Co-deletion of chromosome 1p/19q and IDH1/2 mutation in glioma subsets of brain tumors in Chinese patients.
Ren X; Cui X; Lin S; Wang J; Jiang Z; Sui D; Li J; Wang Z
PLoS One; 2012; 7(3):e32764. PubMed ID: 22427879
[TBL] [Abstract][Full Text] [Related]
18. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
[TBL] [Abstract][Full Text] [Related]
19. MR Elastography Analysis of Glioma Stiffness and
Pepin KM; McGee KP; Arani A; Lake DS; Glaser KJ; Manduca A; Parney IF; Ehman RL; Huston J
AJNR Am J Neuroradiol; 2018 Jan; 39(1):31-36. PubMed ID: 29074637
[TBL] [Abstract][Full Text] [Related]
20. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Sanson M; Marie Y; Paris S; Idbaih A; Laffaire J; Ducray F; El Hallani S; Boisselier B; Mokhtari K; Hoang-Xuan K; Delattre JY
J Clin Oncol; 2009 Sep; 27(25):4150-4. PubMed ID: 19636000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
